93 related articles for article (PubMed ID: 21827725)
1. Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis.
Astrup AS
Dan Med Bull; 2011 Aug; 58(8):B4152. PubMed ID: 21827725
[No Abstract] [Full Text] [Related]
2. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
Grauslund J
Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
[TBL] [Abstract][Full Text] [Related]
3. HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes.
Groop PH; Thomas MC; Rosengård-Bärlund M; Mills V; Rönnback M; Thomas S; Forsblom C; Taskinen MR; Viberti G
Diabetes Care; 2007 Oct; 30(10):2706-7. PubMed ID: 17620444
[No Abstract] [Full Text] [Related]
4. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
[TBL] [Abstract][Full Text] [Related]
5. Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.
Jorsal A; Tarnow L; Flyvbjerg A; Parving HH; Rossing P; Rasmussen LM
Diabetologia; 2008 Nov; 51(11):2100-7. PubMed ID: 18719882
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes.
Lehto S; Rönnemaa T; Pyörälä K; Laakso M
Diabetologia; 2000 Feb; 43(2):148-55. PubMed ID: 10753035
[TBL] [Abstract][Full Text] [Related]
7. Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus.
Rossing P
Diabet Med; 1998 Nov; 15(11):900-19. PubMed ID: 9827844
[TBL] [Abstract][Full Text] [Related]
8. Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
Costacou T; Lopes-Virella MF; Zgibor JC; Virella G; Otvos J; Walsh M; Orchard TJ
J Diabetes Complications; 2005; 19(4):183-93. PubMed ID: 15993351
[TBL] [Abstract][Full Text] [Related]
9. Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study.
Nin JW; Ferreira I; Schalkwijk CG; Jorsal A; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
Diabetologia; 2012 Sep; 55(9):2489-93. PubMed ID: 22752054
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) and atherosclerotic disease in insulin-dependent diabetic patients with declining glomerular filtration rate.
Earle KA; Mattock M; Morocutti A; Aravanitis D; Viberti GC
Diabet Med; 1996 Dec; 13(12):1071-2. PubMed ID: 8973890
[No Abstract] [Full Text] [Related]
11. Long-term mortality and retinopathy in type 1 diabetes.
Grauslund J
Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
[TBL] [Abstract][Full Text] [Related]
12. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland.
Tuomilehto J; Borch-Johnsen K; Molarius A; Forsén T; Rastenyte D; Sarti C; Reunanen A
Diabetologia; 1998 Jul; 41(7):784-90. PubMed ID: 9686919
[TBL] [Abstract][Full Text] [Related]
13. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of excess cardiovascular mortality in diabetes.
Keen H; Ashton CE
Postgrad Med J; 1989; 65 Suppl 1():S26-9. PubMed ID: 2695907
[No Abstract] [Full Text] [Related]
15. [Prognosis of juvenile-onset diabetes].
Tuomilehto J; Lounamaa R
Duodecim; 1990; 106(9):715-23. PubMed ID: 1670363
[No Abstract] [Full Text] [Related]
16. The impact of a family history of Type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with Type I (insulin-dependent) diabetes mellitus.
Fagerudd JA; Pettersson-Fernholm KJ; Grönhagen-Riska C; Groop PH
Diabetologia; 1999 May; 42(5):519-26. PubMed ID: 10333042
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and diabetic nephropathy - a worldwide problem.
Lameire N
Acta Diabetol; 2004 Mar; 41 Suppl 1():S3-5. PubMed ID: 15103541
[No Abstract] [Full Text] [Related]
18. [Development of diabetic complications and long-term prognosis in juvenile-onset diabetes mellitus].
Matsushima M; Shimizu K; Tajima N
Nihon Rinsho; 1997 Nov; 55 Suppl():550-7. PubMed ID: 9434527
[No Abstract] [Full Text] [Related]
19. Homocysteine concentrations in patients with diabetes mellitus--relationship to microvascular and macrovascular disease.
Elias AN; Eng S
Diabetes Obes Metab; 2005 Mar; 7(2):117-21. PubMed ID: 15715884
[No Abstract] [Full Text] [Related]
20. Limited joint mobility is associated with the presence but does not predict the development of microvascular complications in type 1 diabetes.
Arkkila PE; Kantola IM; Viikari JS; Rönnemaa T; Vähätalo MA
Diabet Med; 1996 Sep; 13(9):828-33. PubMed ID: 8891458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
